Psychometric properties of a questionnaire to measure adherence to treatment in patients with type 1 diabetes mellitus
Aim To validate the psychometric properties of a questionnaire to measure adherence to treatment among people with type 1 diabetes mellitus and to evaluate its relationship with metabolic control. Design A cross‐sectional study of 167 adult people with type 1 diabetes mellitus recruited from the End...
Saved in:
Published in: | Nursing open Vol. 9; no. 4; pp. 2139 - 2148 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
John Wiley & Sons, Inc
01-07-2022
John Wiley and Sons Inc Wiley |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aim
To validate the psychometric properties of a questionnaire to measure adherence to treatment among people with type 1 diabetes mellitus and to evaluate its relationship with metabolic control.
Design
A cross‐sectional study of 167 adult people with type 1 diabetes mellitus recruited from the Endocrinology Service of University Hospital Doctor Peset (Spain).
Methods
The validity of the content, construct and reliability of the instrument were evaluated and the results correlated with levels of glycosylated haemoglobin.
Results
The questionnaire was composed of 25 items and 5 dimensions, with a score of 25–150 points and an internal consistency of 0.92, according to Cronbach's coefficient α. The content of validity ratio and the construct (exploratory functional analysis, Kaiser–Meyer–Olkin index and Barlett's spherical test) were adequate. We observed a significant correlation between glycosylated haemoglobin levels and treatment adherence.
Conclusion
The questionnaire to measure adherence to treatment in type 1 diabetes mellitus is consistent, reliable and valid, showing an excellent association with degree of metabolic control. |
---|---|
Bibliography: | Funding information This study was financed by a grant (PI18/00932) from the Carlos III Institute of Health and the European Regional Development Fund (ERDF, ‘A Way of Doing Europe’). C.G‐DV is a beneficiary of a PFIS contract (FI19/00076) and C.B. is a beneficiary of a Miguel Servet type I contract from Carlos III Institute of Health (CP19/00077). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2054-1058 2054-1058 |
DOI: | 10.1002/nop2.1224 |